Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 18/20 | 0.44 |
| ▸ | CTSD | P07339 | 10/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2283866 | 0.92 | BACE1 (0.49) | BACE1CTSD | |
| SCHEMBL2283872 | 0.92 | BACE1 (0.49) | BACE1CTSD | |
| SCHEMBL3395335 | 0.88 | BACE1 (0.46) | BACE1CTSD | |
| SCHEMBL3395835 | 0.84 | BACE1 (0.44) | BACE1CTSDKMT2A | |
| SCHEMBL2284321 | 0.82 | BACE1 (0.52) | BACE1CTSD | |
| SCHEMBL2284324 | 0.82 | BACE1 (0.52) | BACE1CTSD | |
| SCHEMBL13825322 | 0.81 | BACE1 (0.49) | BACE1CTSD | |
| SCHEMBL2281219 | 0.79 | BACE1 (0.55) | BACE1CTSDAPP | |
| SCHEMBL2281215 | 0.79 | BACE1 (0.55) | BACE1CTSDAPP | |
| SCHEMBL2280069 | 0.79 | BACE1 (0.64) | BACE1CTSDBACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2245019-A1 | 4, 5-DIHYDRO-OXAZOL-2-YL AMINE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2010-11-03 | — | — | EP | disclosed |
| WO-2009103626-A1 | 4, 5-DIHYDRO-OXAZOL-2-YL AMINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2009-08-27 | — | — | WO | disclosed |